Multilink™, a new linker technology for increasing drug-to-antibody ratio (DAR)

Presented at the World ADC 2020, London, UK

Nathalie Bellocq¹, Noemie Luong², Léo Marx¹, Mathilde Pantin¹, Manfred Mutter¹, Daniel Biasse², Antoine Attinger², Patrick Garrouste¹

¹ Debiopharm Research & Manufacturing SA, Rue du Levant 146, CH-1920 Martigny, Switzerland

² Debiopharm International SA, Chemin Messidor 5-7, CH-1006 Lausanne, Switzerland